| scholarly article | Q13442814 |
| P2093 | author name string | Rafael Cantón | |
| Fernando Baquero | |||
| Teresa M Coque | |||
| P2860 | cites work | Environmental reservoirs and mechanisms of persistence of Vibrio cholerae | Q21131113 |
| Heavy metal driven co-selection of antibiotic resistance in soil and water bodies impacted by agriculture and aquaculture | Q21131130 | ||
| Using epigenetics to define vaccine-induced memory T cells | Q26849423 | ||
| Review of institute of medicine and national research council recommendations for one health initiative | Q26853206 | ||
| Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review | Q27008867 | ||
| Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany | Q28244221 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| "One-size-fits-all"? Optimizing treatment duration for bacterial infections | Q28478851 | ||
| Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains | Q28485487 | ||
| The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations | Q28485988 | ||
| Aggressive chemotherapy and the selection of drug resistant pathogens | Q28533328 | ||
| Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance | Q28534880 | ||
| Antibiotic resistance gene abundances correlate with metal and geochemical conditions in archived Scottish soils | Q28742957 | ||
| Whole-genome sequencing and social-network analysis of a tuberculosis outbreak | Q29614802 | ||
| Transforming clinical microbiology with bacterial genome sequencing. | Q30356166 | ||
| Barriers and bridges to infection prevention and control: results of a qualitative case study of a Netherlands' surgical unit | Q30509493 | ||
| Evolution in health and medicine Sackler colloquium: Evolution and public health | Q33517441 | ||
| The shared antibiotic resistome of soil bacteria and human pathogens | Q33804392 | ||
| An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective. | Q33853477 | ||
| How to make predictions about future infectious disease risks | Q33916044 | ||
| Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital | Q34243748 | ||
| Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions | Q34298437 | ||
| Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals | Q34340879 | ||
| The scourge of antibiotic resistance: the important role of the environment | Q34347746 | ||
| Dendritic-cell-based therapeutic cancer vaccines | Q34360094 | ||
| Antibiotic resistance-the need for global solutions | Q34386251 | ||
| Multicomponent therapeutics for networked systems | Q34390417 | ||
| A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm | Q34555658 | ||
| Microbial genomics and infectious diseases | Q34631250 | ||
| Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development | Q38155063 | ||
| Vaccines, reverse vaccinology, and bacterial pathogenesis | Q39426398 | ||
| Natural antibiotic resistance and contamination by antibiotic resistance determinants: the two ages in the evolution of resistance to antimicrobials | Q40385075 | ||
| Predictions: evolutionary trajectories and planet medicine | Q41957295 | ||
| On the shifting balance: the case of Staphylococcus aureus CC398. | Q42549088 | ||
| Immunological monitoring of anticancer vaccines in clinical trials | Q42734281 | ||
| Infectious diseases of animals and plants: an interdisciplinary approach | Q42788188 | ||
| The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance | Q42956779 | ||
| Exploring the role of the immune response in preventing antibiotic resistance | Q44028719 | ||
| Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. | Q44968635 | ||
| Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance | Q46221499 | ||
| Effect of manure application on abundance of antibiotic resistance genes and their attenuation rates in soil: field-scale mass balance approach. | Q46523044 | ||
| Finland, Weinstein, and the birth of antibiotic regret | Q48417116 | ||
| Ecology drives a global network of gene exchange connecting the human microbiome. | Q51171065 | ||
| Antibiotic interactions that select against resistance. | Q51710862 | ||
| Recent advances in the potential interconnection between antimicrobial resistance to biocides and antibiotics. | Q53112603 | ||
| An overview of emerging therapies for the treatment of chronic hepatitis C | Q86830434 | ||
| Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria | Q34631478 | ||
| Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers | Q34782459 | ||
| Prevalence of antibiotic resistance genes and bacterial community composition in a river influenced by a wastewater treatment plant | Q35036836 | ||
| The relationship between lay and technical views of Escherichia coli O157 risk. | Q35088435 | ||
| The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy | Q35092451 | ||
| Systematic discovery of multicomponent therapeutics | Q35147474 | ||
| Plasmid introduction in metal-stressed, subsurface-derived microcosms: plasmid fate and community response. | Q35154771 | ||
| Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development. | Q35206728 | ||
| Contribution of interfacility patient movement to overall methicillin-resistant Staphylococcus aureus prevalence levels | Q35902729 | ||
| Multilevel analysis of infectious diseases | Q35997344 | ||
| Combination therapy for treatment of infections with gram-negative bacteria | Q36156077 | ||
| Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing | Q36464896 | ||
| Defining principles of combination drug mechanisms of action | Q36535401 | ||
| Evaluating treatment protocols to prevent antibiotic resistance | Q36637189 | ||
| High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients | Q36845508 | ||
| Country-specific antibiotic use practices impact the human gut resistome | Q36973632 | ||
| Genomic evolution and transmission of Helicobacter pylori in two South African families. | Q37117938 | ||
| Epidemiology and control of trachoma: systematic review. | Q37165258 | ||
| Antibiotics and antibiotic resistance in water environments | Q37183790 | ||
| The FDA reboot of antibiotic development | Q37263756 | ||
| Towards an ecological approach to antibiotics and antibiotic resistance genes | Q37394204 | ||
| Prophylactic and therapeutic vaccines for obesity | Q37473523 | ||
| Contribution of phenotypic heterogeneity to adaptive antibiotic resistance. | Q37475114 | ||
| Microbiota restoration: natural and supplemented recovery of human microbial communities | Q37813012 | ||
| Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance | Q37876027 | ||
| Elderly patients with community-acquired pneumonia: optimal treatment strategies | Q37896600 | ||
| Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum | Q37933370 | ||
| Green pharmacy and pharmEcovigilance: prescribing and the planet | Q37960637 | ||
| Are humans increasing bacterial evolvability? | Q37998201 | ||
| Metagenomic epidemiology: a public health need for the control of antimicrobial resistance | Q38014571 | ||
| Omics and drug response | Q38058836 | ||
| The ecological habitat and transmission of Escherichia coli O157:H7. | Q38072999 | ||
| The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria | Q38076545 | ||
| Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis | Q38076970 | ||
| Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease | Q38094958 | ||
| Group A streptococcal vaccines: paving a path for accelerated development | Q38100042 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic resistance | Q380775 |
| P304 | page(s) | 851-861 | |
| P577 | publication date | 2014-05-31 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Counteracting antibiotic resistance: breaking barriers among antibacterial strategies | |
| P478 | volume | 18 |
| Q35737979 | A membrane computing simulator of trans-hierarchical antibiotic resistance evolution dynamics in nested ecological compartments (ARES). |
| Q38569678 | How to use vancomycin optimally in neonates: remaining questions |
| Q38558374 | Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives. |
| Q36267035 | Membrane-permeabilizing activity of reverse-amide 2-aminoimidazole antibiofilm agents against Acinetobacter baumannii |
| Q26781119 | Phage therapy of pulmonary infections |
| Q35236703 | Public health evolutionary biology of antimicrobial resistance: priorities for intervention |
| Q28067846 | Towards the just and sustainable use of antibiotics |
Search more.